Overweight and obesity as risk factors for biochemical recurrence of prostate cancer after radical prostatectomy

被引:6
作者
Kim, Sung Jin [1 ]
Park, Min Uk [2 ]
Chae, Han Kyu [1 ]
Nam, Wook [1 ]
Kim, So Won [3 ]
Yu, Hoon [4 ]
Kim, Han Gwun [1 ]
Kang, Gil Hyun [5 ]
Park, Jong Yeon [1 ]
机构
[1] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Urol, Kangnung, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pharmacol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Nephrol, Kangnung, South Korea
[5] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Pathol, Kangnung, South Korea
关键词
Prostate cancer; Biochemical recurrence; Body mass index; Obesity; BODY-MASS INDEX; ANTIGEN DENSITY; ASSOCIATION; AMERICAN; MEN;
D O I
10.1007/s10147-021-02058-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Previous studies have shown a relationship between the occurrence and recurrence of prostate cancer; however, this relationship remains controversial. We investigated the relationship between obesity and biochemical recurrence in patients with prostate cancer. Methods Clinicopathological factors were analyzed after dividing the patient population according to the Asian population-specific body mass index (BMI) criteria for "normal" (< 23 kg/m(2)), "overweight" (23-27.5 kg/m(2)), and "obese" (>= 27.5 kg/m(2)). Among the 389 patients included in this study, 108 were classified as normal, while 227 and 54 patients were classified as overweight and obese, respectively. The relationships between clinicopathological factors and biochemical recurrence were analyzed by univariate and multivariate Cox <= proportional hazard models. Biochemical recurrence was defined as two consecutive prostate-specific antigen (PSA) measurements >= 0.2 ng/mL. Results In univariate analysis, the categorical variables of "overweight" and "obese" were significant prognostic factors for biochemical recurrence. In multivariate analysis models including PSA density [hazard ratio (HR) 1.8, p = 0.01], extraprostatic extension (HR 2.0, p < 0.001), Gleason score (HR 1.7, p = 0.01), surgical margin positivity (HR 2.46, p < 0.001), and lymphovascular invasion (HR 2.53, p < 0.001), the categorical variables of "overweight" (HR 1.6, p = 0.03) and "obese" (HR 1.76, p = 0.035) were prognostic factors for biochemical recurrence. Conclusion The obesity status of patients with prostate cancer as "overweight" and "obese" was a risk factor for biochemical recurrence after adjusting for other clinicopathological factors.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 36 条
[1]   Obesity and Prostate Cancer: Weighing the Evidence [J].
Allott, Emma H. ;
Masko, Elizabeth M. ;
Freedland, Stephen J. .
EUROPEAN UROLOGY, 2013, 63 (05) :800-809
[2]   PROSTATE SPECIFIC ANTIGEN DENSITY - A MEANS OF DISTINGUISHING BENIGN PROSTATIC HYPERTROPHY AND PROSTATE-CANCER [J].
BENSON, MC ;
WHANG, IS ;
PANTUCK, A ;
RING, K ;
KAPLAN, SA ;
OLSSON, CA ;
COONER, WH .
JOURNAL OF UROLOGY, 1992, 147 (03) :815-816
[3]   Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada [J].
Blanc-Lapierre, Audrey ;
Spence, Andrea ;
Karakiewicz, Pierre I. ;
Aprikian, Armen ;
Saad, Fred ;
Parent, Marie-Elise .
BMC PUBLIC HEALTH, 2015, 15
[4]   Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer [J].
Brassell, SA ;
Kao, TC ;
Sun, L ;
Moul, JW .
UROLOGY, 2005, 66 (06) :1229-1233
[5]  
Chang S, 2002, CANCER EPIDEM BIOMAR, V11, P758
[6]  
Ciudin A, 2014, ENDOCRINOL NUTR, V61, P147, DOI 10.1016/j.endonu.2013.10.004
[7]   Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer update panel report and recommendations for a standard in the reporting of surgical outcomes [J].
Cookson, Michael S. ;
Aus, Gunnar ;
Burnett, Arthur L. ;
Canby-Hagino, Edith D. ;
D'Amico, Anthony V. ;
Dmochowski, Roger R. ;
Eton, David T. ;
Forman, Jeffrey D. ;
Goldenberg, S. Larry ;
Hernandez, Javier ;
Higano, Celestia S. ;
Kraus, Stephen R. ;
Moul, Judd W. ;
Tangen, Catherine ;
Thrasher, J. Brantley ;
Thompson, Ian .
JOURNAL OF UROLOGY, 2007, 177 (02) :540-545
[8]   Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates [J].
Culp, MaryBeth B. ;
Soerjomataram, Isabelle ;
Efstathiou, Jason A. ;
Bray, Freddie ;
Jemal, Ahmedin .
EUROPEAN UROLOGY, 2020, 77 (01) :38-52
[9]   Obesity as a Major Risk Factor for Cancer [J].
De Pergola, Giovanni ;
Silvestris, Franco .
JOURNAL OF OBESITY, 2013, 2013
[10]   Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents [J].
Di Angelantonio, Emanuele ;
Bhupathiraju, Shilpa N. ;
Wormser, David ;
Gao, Pei ;
Kaptoge, Stephen ;
de Gonzalez, Amy Berrington ;
Cairns, Benjamin J. ;
Huxley, Rachel ;
Jackson, Chandra L. ;
Joshy, Grace ;
Lewington, Sarah ;
Manson, JoAnn E. ;
Murphy, Neil ;
Patel, Alpa V. ;
Samet, Jonathan M. ;
Woodward, Mark ;
Zheng, Wei ;
Zhou, Maigen ;
Bansal, Narinder ;
Barricarte, Aurelio ;
Carter, Brian ;
Cerhan, James R. ;
Collins, Rory ;
Smith, George Davey ;
Fang, Xianghua ;
Franco, Oscar H. ;
Green, Jane ;
Halsey, Jim ;
Hildebrand, Janet S. ;
Jung, Keum Ji ;
Korda, Rosemary J. ;
McLerran, Dale F. ;
Moore, Steven C. ;
O'Keeff, Linda M. ;
Paige, Ellie ;
Ramond, Anna ;
Reeves, Gillian K. ;
Rolland, Betsy ;
Sacerdote, Carlotta ;
Sattar, Naveed ;
Sofianopoulou, Eleni ;
Stevens, June ;
Thun, Michael ;
Ueshima, Hirotsugu ;
Yang, Ling ;
Yun, Young Duk ;
Willeit, Peter ;
Banks, Emily ;
Beral, Valerie ;
Chen, Zhengming .
LANCET, 2016, 388 (10046) :776-786